ZVR 300 (Zidovudine 300 mg)

Pill imprint ZVR 300 has been identified as Zidovudine 300 mg.

Zidovudine is used in the treatment of hiv infection; reduction of perinatal transmission of hiv; occupational exposure; nonoccupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Zidovudine 300 mg is not a controlled substance under the Controlled Substance Act (CSA).

Zidovudine

Imprint:

ZVR 300

Strength:

300 mg

Color:

White

Shape:

Round

Availability:

Prescription only

Drug Class:

Nucleoside reverse transcriptase inhibitors (NRTIs)

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Manufacturer:

Cipla Ltd.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.